|
|
||||||||
1 Pathophysiology Research Laboratory, National Children's Medical Research Center, Tokyo 154-8509, Japan; and 2 Division of Respiratory and Critical Care, Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada M5B 1W8
| |
ABSTRACT |
|---|
|
|
|---|
This study compared
pathophysiological and biochemical indexes of acute lung injury in a
saline-lavaged rabbit model with different ventilatory strategies: a
control group consisting of moderate tidal volume (VT)
(10-12 ml/kg) and low positive end-expiratory pressure (PEEP)
(4-5 cmH2O); and three protective groups:
1) low VT (5-6 ml/kg) high PEEP, 2-3
cmH2O greater than the lower inflection point;
2) low VT (5-6 ml/kg), high PEEP (8-10
cmH2O); and 3) high-frequency oscillatory
ventilation (HFOV). The strategy using PEEP > inflection point
resulted in hypotension and barotrauma. HFOV attenuated the decrease in
pulmonary compliance, the lung inflammation assessed by
polymorphonuclear leukocyte infiltration and tumor necrosis factor-
concentration in the alveolar space, and pathological changes of the
small airways and alveoli. Conventional mechanical ventilation using
lung protection strategies (low VT high PEEP) only
attenuated the decrease in oxygenation and pulmonary compliance. Therefore, HFOV may be a preferable option as a lung protection strategy.
ventilator-induced lung injury; volume recruitment; tumor necrosis factor; conventional mechanical ventilation
| |
INTRODUCTION |
|---|
|
|
|---|
MECHANICAL VENTILATION IS essential for patients with respiratory or ventilatory failure. However, the ventilatory strategies used in many patients with the acute respiratory distress syndrome (ARDS) or acute lung injury may worsen the lung injury. A number of experimental studies have demonstrated that a ventilatory strategy that overdistends alveolar units and/or allows repeated tidal collapse and reopening of damaged lung units may induce lung injury. This indicates that both the magnitude of cyclic fluctuations of alveolar volume [tidal volume (VT)] and the level of end-expiratory alveolar volume may be important in ventilator-induced lung injury (VILI) (11, 31, 40).
Various "lung protection" strategies have been developed to minimize VILI. One strategy uses conventional mechanical ventilation (CMV) with decreased VT and increased positive end-expiratory pressure (PEEP), titrated to the pressure-volume (P-V) curve. Amato and co-workers (2) showed improved survival and decreased incidence of barotrauma in a group treated with an "open lung" approach that employed volume recruitment maneuvers, higher PEEP levels (adjusted on the basis of an initial P-V curve), and a VT of 6 ml/kg. Ranieri and co-workers (34) used a similar strategy and reported a decrease in pulmonary and systemic cytokines in patients with ARDS. More recently, the ARDS Net investigators reported a 22% decrease in mortality of patients with ARDS using a protective conventional strategy aimed at reducing end-inspiratory stretch. This study used a small VT (6 ml/kg predicted body wt) with a PEEP that averaged ~9 cmH2O (1).
These strategies are based on the same concepts underlying the protective advantages of high-frequency oscillatory ventilation (HFOV) (13, 26). HFOV allows the use of extremely small VTs, often less than the anatomical dead space. During HFOV, it is possible to maintain end-expiratory lung volume higher up on the deflation P-V relationship without inducing concurrent overdistention because of the much smaller VTs used (13). There are convincing animal data indicating reduced lung injury with HFOV. Studies in premature primates and saline-lavaged adult rabbits demonstrated that, when compared with conventional ventilation, HFOV improves gas exchange, promotes uniform lung inflation, and reduces lung injury (10, 27, 45). HFOV is also associated with reduced inflammatory mediators and granulocytes in lung lavage samples when compared with conventional ventilation (18, 25, 42, 43).
Thus there are two general ventilatory approaches to lung protection,
one based on conventional ventilation and one based on high-frequency
ventilation. It is unclear from the literature whether there is an
advantage of one approach over the other. The present study set out to
examine this issue using a rabbit lung lavage model. We compared
different ventilatory strategies: a control group consisting of
moderate VT (10-12 ml/kg) and low PEEP (4-5
cmH2O) (MVLP), and three protective groups: 1)
low VT (5-6 ml/kg) high PEEP, 2-3
cmH2O greater than the lower inflection point
(Pinf); 2) low VT (5-6 ml/kg),
high PEEP (8-10 cmH2O) (LVHP); and 3) HFOV.
End points were pathophysiological indexes of acute lung injury: gas
exchange, lung compliance, the number of polymorphonuclear leukocytes
(PMN), levels of tumor necrosis factor-
(TNF-
) in lung lavage
fluid, and lung pathology.
| |
METHODS |
|---|
|
|
|---|
The study protocol was reviewed and approved by the Institutional Animal Research Committee.
Animal Preparation
Adult male Japanese White rabbits (2.5-3.2 kg) were premedicated with an intramuscular injection of ketamine hydrochloride (10 mg/kg). A venous line was established for fluid maintenance, and the animals were anesthetized and paralyzed by a continuous intravenous infusion of ketamine (8 mg/h) and pancuronium bromide (0.3 mg/h) in 10 ml · kg
1 · h
1 of 5%
dextrose in Ringer lactate solution. A tracheostomy was performed, and
a 4.0-mm-ID endotracheal tube was inserted and fixed in place while the
animal was manually ventilated at an inspired O2 fraction
(FIO2) of 1.0 for 3-4 min.
Immediately after tracheostomy, ventilation was initiated with a piston
pump HFOV ventilator (Humming V; Senko Medical Instrument
Manufacturers, Tokyo, Japan). We used HFOV for preparation and
stabilization, as described later in detail, because we and others have
previously demonstrated that HFOV minimizes lung injury in this
saline-lavaged rabbit lung model (16, 18, 25, 42, 43).
Sinusoidal volume changes were delivered at an
FIO2 of 1.0, an oscillatory frequency of
15 Hz, and a mean airway pressure (MAP) of 7 cmH2O. The
stroke volume was adjusted to keep arterial CO2 partial
pressure (PaCO2) levels between 30 and 50 Torr. Blood
pressure was measured through a fluid-filled catheter in the carotid
artery. Arterial blood gases were intermittently measured by a
pH/blood-gas analyzer (model 178, Corning, Medfield, MA). Systemic
arterial blood pressure was continuously monitored by a pressure
transducer (CDX-3, Cobe Laboratories), and body temperature was
maintained between 38 and 39°C with a servo-controlled radiant heater
and a heating pad.
After stabilization, the rabbits' lungs were lavaged with 30 ml/kg of warmed normal saline to remove lung surfactant. The solution was flushed in and out of the lungs five times, and the saline was gently sucked out at the end of each lavage. This procedure was repeated two times by using the same protocol described by Hamilton et al. (16). The fluid obtained from the lavage procedure was stored and analyzed as the "before ventilation" control. The percentage of lavage fluid recovered was 81 ± 6%.
MAP was raised by 5 cmH2O, and a sustained inflation (SI) to 30 cmH2O for 15 s was performed several times after the lavage for all experiments. After completion of this procedure, MAP was set at 15 cmH2O and stabilized, PaCO2 levels were maintained between 30 and 50 Torr by adjusting stroke volume, and the frequency was fixed at 15 Hz during HFOV. With several SI maneuvers, the arterial O2 partial pressure (PaO2) of the animals soon returned to prelavage levels, i.e., >350 Torr.
Experimental Protocol
Pilot study using a PEEP > lower Pinf strategy. To determine whether HFOV is better or worse than a conventional strategy requires the use of a specific conventional strategy. Because there is no generally agreed on optimal strategy, we chose to study two strategies that have been shown to decrease mortality in two recent randomized controlled trials: 1) a strategy similar to that of Amato et al. (2) with small VT and PEEP > Pinf, and 2) a strategy similar to the National Institutes of Health (NIH) trial (1) using small VT and PEEP ~10 cmH2O. We started with a pilot study to assess the feasibility of using a strategy based on Pinf in this rabbit model. In eight animals, after preparation of the animals and lung lavage as described above, we inflated the lungs twice to an airway opening pressure of 30 cmH2O and then measured a quasi-static P-V curve of the respiratory system. The quasi-static P-V curve was constructed by slowly, manually inflating the lungs using fixed-volume steps up to a pressure of 30 cmH2O. The deflation loop of the static P-V curve was then constructed by withdrawing air in the same manner. The Pinf was determined as described by Matamis et al. (24). After a SI to 30 cmH2O for 15 s was performed several times, the animals were ventilated by using the CMV mode of the Humming V (time-cycled with pressure-limited ventilation mode) with a low VT (5-6 ml/kg) and PEEP 2-3 cmH2O > Pinf (n = 4) for 4 h using an FIO2 of 1.0. VT was maintained at 5-6 ml/kg by adjusting peak inspiratory pressure (PIP). VT, PIP, and MAP were monitored at the proximal end of the endotracheal tube with the airway monitoring mode of a pulmonary function monitor (model GM250 navigator; Newport Medical Instruments, Newport Beach, CA). PEEP was monitored at the same site with a pressure transducer. Arterial blood gases were measured every hour, and systemic arterial blood pressure was continuously monitored. Although we achieved excellent oxygenation, three of four animals developed systemic hypotension and metabolic acidosis and/or pneumothorax. Therefore, in the second set of experiments, we used a value of PEEP = 8-9 cmH2O at the beginning of the first 1 h and 10 cmH2O over the following 3 h in the low VT, high PEEP (LVHP) group. We also used a VT of 5-6 ml/kg in the LVHP group, volumes that are very similar to those used in the recently reported NIH ARDS Net trial (1).
Main experiment.
Given the results of the pilot study, the main set of experiments was
carried out with the use of a protective ventilatory strategy that is
similar to the recently reported NIH trial (1). The
rabbits were randomly divided into three groups [MVLP
(n = 7), LVHP (n = 6), and HFOV
(n = 6)] and were then ventilated for 4 h at an
FIO2 of 1.0. In the MVLP group, PEEP was
4-5 cmH2O and VT was maintained at
10-12 ml/kg by adjusting PIP. In the LVHP group, PEEP was set at
8-9 cmH2O for the first hour and then gradually increased to 10 cmH2O over the following 3 h, so as to
minimize the systemic hypotension. VT was maintained at
5-6 ml/kg by adjusting PIP. In the HFOV group, MAP was set at 15 cmH2O. Normocapnia was achieved by altering the stroke
volume of the piston. Arterial blood gases were measured every hour
with a blood-gas analyzer (model 178, Corning). Total respiratory
compliance (Crs) was measured before lung lavage and after 4 h of
ventilation. The animals were killed by KCl injection at the
termination of the experiment, and the lungs were excised via a midline
sternotomy. The left lung was then lavaged two times using 15 ml/kg
aliquots of normal saline. The drained lavage fluid was collected as in
the sample after ventilation. The percentage of lavage fluid recovered
was 67 ± 9%. The right lung was fixed with an instillation of
10% buffered formalin at a transpulmonary pressure of 15 cmH2O. We compared pathophysiological indexes as follows:
gas exchange, Crs before lung lavage and after 4 h of ventilation,
numbers of PMN, the levels of TNF-
in the lung lavage fluid, and
lung pathological findings at the end of the experiment.
Measurement of Crs
We measured Crs with the static occlusion method by using the passive mechanics (occlusion) mode of a pulmonary function monitor (model GM250 navigator, Newport Medical Instruments). Airway pressures and volumes were measured both at the beginning of inspiration and at the occlusion plateau by using pressure and flow transducers. Crs was then automatically calculated by using linear regression as the chord slope of the P-V line.Cells, PMN, and Macrophage Counts in Lung Lavage Fluid
The total number of lavaged cells was counted by a standard hemocytometer. Cells were differentiated by use of Wright-Giemsa-stained preparations, and the percent of PMN and macrophages was assessed.Measurement of TNF-
Concentrations in the Lung Lavage
Fluid
concentrations in the lung lavage fluid were assayed
using a sandwich ELISA based on the cytokine ELISA protocol of PharMingen (San Diego, CA) as described previously (17).
These assays were performed using a purified polyclonal goat
anti-rabbit TNF-
antibody as a capture antibody and biotinylated
polyclonal goat anti-rabbit TNF-
antibody for detection. The rabbit
TNF-
-conditioned medium (PharMingen) was used as a standard, and
samples were run in duplicate. The limit of detection in this assay was
50 pg/ml, and linear standard curves were obtained ranging from 75 to
15,000 pg/ml.
Histopathological Examination
After fixation, the right lung was floated in 10% formalin for at least 24 h. The lung was then serially sectioned in a coronal fashion from apex to base, and four random sections from a lung were processed for pathological analysis and embedded in paraffin. Thereafter, each section was sliced to 5 µm and was stained with hematoxylin-eosin and Masson's trichrome. We assessed the lungs (four sections per lung) using a five-point scale according to combined assessments of alveolar congestion, hemorrhage, infiltration or aggregation of neutrophils in the air space or vessel walls, thickness of the alveolar wall, and hyaline membrane formation. The scoring was as follows: 0 = minimal (little) damage, 1+ = mild damage, 2+ = moderate damage, 3+ = severe damage, and 4+ = maximal damage.Membranous bronchioles are conducting airways without cartilage and include terminal bronchioles, which are the most distal generation of membranous bronchioles and the patent generation to respiratory bronchioles. Four membranous bronchioles per section (16 bronchioles per lung) were processed for pathological scoring. Six pathological abnormalities were evaluated, including degree of inflammatory cell infiltration, fibrosis, smooth muscle hypertrophy, presence of pigment, goblet cell metaplasia, and squamous cell metaplasia. We assigned a score ranging from 0 (normal) to 3 for each of these pathological variables. The airway changes were evaluated by the method of Wright et al. (51), compared with a panel of standard photographs (kindly provided by J. C. Hogg, St. Paul's Hospital, Vancouver, Canada).
Data Analysis
Results are presented as means ± SD. We used a two-way ANOVA to determine the statistical significance of intergroup differences in blood-gas data at different time points, Crs, numbers of PMN in the final lavage fluid, the levels of log TNF-
in the lung lavage fluid before and after ventilation, and the scoring of lung
pathology. A P value <0.05 was considered statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Pilot Study
After lung lavage, the lower Pinf was 9.3 ± 1.1 cmH2O. As described above, because we had profound hypotension and gross barotrauma in this group of animals, we did not complete any other analysis on this group.Main Experiment
Gas exchange.
The ventilation protocols resulted in no significant differences in MAP
(Fig. 1). PaO2 was
highest in the HFOV group and lowest in the MVLP group.
PaO2 of the LVHP group was between the values of HFOV
and MVLP groups (Fig. 2).
PaCO2 was higher in the LVHP group than in the MVLP or
HFOV groups, and pH was lower in the LVHP group than in the MVLP or
HFOV groups (Fig. 3). The values of Crs
after ventilation were lower in the MVLP group than in the HFOV and
LVHP groups (P < 0.01) and were also lower in the LVHP
group than in the HFOV group (P < 0.05) (Fig.
4).
|
|
|
|
Cell and PMN count.
Following the ventilatory period, the recovered cells from the lung
lavage included macrophages and PMN. The number of PMN was lower in the
HFOV group than in the LVHP and MVLP groups (P < 0.01). No significant differences were seen between the LVHP and MVLP
groups (Fig. 5).
|
Levels of TNF-
in the lung lavage fluid before and after
ventilation.
Levels of TNF-
in the lung lavage fluid before ventilation were not
significantly different among the three groups. Levels of TNF-
after
ventilation were lower in the HFOV group (436 ± 177 pg/ml) than
in the MVLP group (7,366 ± 5,023 pg/ml) (P < 0.01) or in the LVHP group (4,310 ± 1,091 pg/ml)
(P < 0.05). No significant differences were seen
between the MVLP and LVHP groups, although there was a tendency to
lower levels in the LVHP group (Fig. 6).
|
Histopathology.
Similar to previous studies (16, 17, 20, 25) the
pathological findings from the animals in the MVLP group showed
extensive hyaline membrane formation and severe PMN infiltration (Fig.
7A). Expanded lung parenchyma
with well-preserved alveoli and less hyaline membranes were seen in the
lung samples in the HFOV group (Fig. 7C). In the LVHP group,
alveolar injury was severe and similar to the findings in the MVLP
group (Fig. 7, A and B). The pathological scores
are summarized in Table 1. The
quantitative alveolar pathological scores were higher in the
MVLP and LVHP groups than in the HFOV group (P < 0.01). No significant differences were seen between the MVLP and LVHP
groups (Table 1). Pathological findings of the membranous bronchioles
in the MVLP group exhibited a high degree of bronchiolar inflammation,
a moderate degree of goblet cell and squamous cell metaplasia, and a
low degree of fibrosis and muscular hypertrophy (Fig.
8A). In the HFOV group, the
degree of bronchiolar injury was less, especially with regard to
inflammation and squamous cell metaplasia (Fig. 8C). In the
LVHP group, the degree of injury was between the scores of the MVLP and
HFOV groups (Fig. 8B). Results of the individual scores are
presented in Table 2. The pathological
score with respect to membranous bronchioles was higher in the MVLP
group than in the LVHP and HFOV groups (P < 0.01).
|
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The major findings of this study were 1) ventilation
with low VT and high PEEP attenuated the decrease in
oxygenation and pulmonary compliance observed with moderate
VT and low PEEP but did not attenuate lung inflammation
characterized by PMN infiltration and TNF-
production, 2)
HFOV attenuated the decrease in oxygenation and pulmonary compliance,
as well as PMN infiltration and TNF-
production, compared with
strategies using moderate VT and low PEEP or low
VT and high PEEP, and 3) HFOV attenuated the
injury to the alveoli and membranous bronchioles.
The major question in interpreting the results of this study is whether the protective ventilatory strategy using CMV was optimal or at least an accepted conventional lung protective strategy. There is no consensus on what constitutes the optimal strategy, and it is not reasonably possible to ascertain whether a given strategy is "optimal" in terms of outcome. It is, however, possible to assess whether the strategy fulfills present concepts of being adequate for lung protection. The key features of a lung protective strategy are recruitment of the lung and minimization of end-inspiratory stretch (11). We initially used a strategy similar to that used by Amato et al. (2) in which the PEEP was 2-3 cmH2O greater than the lower Pinf base on the inflation limb of the P-V curve. Muscedere and colleagues (28) demonstrated that the use of PEEP > Pinf attenuated lung injury in isolated, nonperfused, lavaged rat lungs. The concept is that Pinf represents the point of initiation of recruitment that such a strategy should lead to greater recruitment of lung than lower levels of PEEP. However, there are a number of questions about the validity of this approach including 1) the fact that the lung is often not fully recruited even if PEEP > Pinf, 2) the effect of the chest wall on Pinf, and 3) the spatial heterogeneity of the disease process in ARDS so that a given value of PEEP may be appropriate for one lung region but too large (or too small) for another region. In our rabbit lung lavage model, this strategy led to hypotension and barotrauma, similar to results of Rimensberger et al. (35). This is in contrast to the study by Amato and colleagues (2), which demonstrated a significant difference in their primary end point (28-day mortality) in their lung protective group, which included a strategy that used PEEP > Pinf. Although such a strategy may be advantageous in humans with ARDS (2), our results may indicate greater sensitivity of this anesthetized rabbit model to hemodynamic compromise with changes in airway pressure, perhaps because of the relatively lower chest wall elastance of rabbits vs. human (36) and/or the relatively smaller volume of the thorax, which may impact on the mechanical compression of the heart caused by PEEP (30).
We then used a strategy similar to that used in the ARDS Net trial (1). In that study, VT was 6 ml/kg (predicted body wt) and PEEP averaged 9 cmH2O. Our LVHP strategy thus fulfilled the two criteria mentioned above for an adequate lung protective strategy: PIP was <25 cmH2O, below values thought to be safe (39), and PaO2 was >300 Torr, indicating adequate recruitment. Further evidence for the adequacy of this approach comes from Rimensberger and colleagues (35), who documented that volume recruitment maneuvers allowed expansion of atelectatic lung units during small VT (5 ml/kg) ventilation and that a PEEP above Pinf was not necessary to maintain recruited lung volume in the same model we used, the saline-lavaged rabbit. Thus it is reasonable to treat the LVHP group as a protective conventional strategy (albeit, possibly not optimal).
Compared with the MVLP group, the LVHP group had improved oxygenation and respiratory compliance. This finding has a number of possible explanations. Mechanical ventilation can result in surfactant loss and in the conversion of surfactant from large aggregates to functionally inferior small aggregates, which may occur to a greater extent in injured lungs. A study in a rabbit lung injury model showed that conversion of large to small aggregates was minimized with a low VT (5 ml/kg) strategy (19). Reduced surfactant conversion to small aggregates may have improved compliance and facilitated oxygenation in the LVHP group. Using computed tomography, Gattinoni and colleagues (14) examined the topographic distribution of gas in injured lungs of ARDS patients and documented that a major factor in the apparent decrease in compliance in patients with ARDS is that the inflated portion of the lung represents a small portion of the total lung volume ("baby-lung" concept). To the extent that certain regions of the lung did not maintain recruitment in the MVLP group, this concept could partly explain the decreased compliance observed in the MVLP group compared with the lungs of the LVHP group. More recently, using parenchymal marker technique, Martynowicz and colleagues (23) documented that regional tidal expansion of dependent regions was significantly reduced after oleic acid injury and was restored by application of PEEP, although oleic acid injury did not lead to the collapse of dependent lung units at functional residual capacity, suggesting an alternative mechanism for topographic variability in regional impedance and lung expansion after injury in a model characterized by marked alveolar flooding.
In the LVHP group, there was a tendency to lower TNF-
concentrations
than the MVLP group, but these values were markedly higher than the
HFOV group. These results are similar to those of Tremblay and
colleagues (44), who found that their MVHP group (VT = 15 ml/kg, PEEP = 10 cmH2O) was
associated with an ~50% decrease in TNF-
compared with a group
with the same VT but zero PEEP in isolated, ex vivo
nonperfused rat lungs. This decrease in TNF-
was roughly the same as
we observed, but the differences did not reach statistical significance
in either study.
HFOV, compared with MVLP and LVHP, resulted in attenuation of the
decrease in oxygenation, pulmonary compliance, as well as PMN
infiltration and TNF-
production in the alveolar space. Our results
suggest that the recruitment of lung volume and the limitation of
alveolar pressure changes during the respiratory cycle using HFOV may
reduce the lung injury caused by mechanical ventilation, compared with
CMV with MVLP or even LVHP. Ranieri and colleagues (33)
demonstrated that patients with ARDS often have no clear Pinf, suggesting a broad distribution of opening pressures
in a nonhomogeneously injured lung. The lung has a spectrum of alveolar volumes and opening and closing pressures that could be affected by
gravitational factors and the distribution of the intrinsic lung
pathology. HFOV may have a larger margin of safety in keeping the lung
open within the desired target range of alveolar reexpansion in
nonhomogeneously injured lungs, compared with CMV even with LVHP.
Venegas and Fredberg (47) studied the selection of
frequency and PEEP values for ventilation of the atelectasis prone
lung. They predicted that the range of "safe" frequency-PEEP
combinations will be narrow and move to higher frequencies as lung
compliance decreases, possibly suggesting the theoretical advantage of
HFOV over CMV with MVLP or even with LVHP in noncompliant lungs.
In our previous study using the same model, we confirmed that
only 1 h of CMV (MVLP) produced large increases in TNF-
mRNA in
intra-alveolar cells (43) and also found that the levels of TNF-
protein in lung lavage fluid were increased after 4 h of ventilation with CMV (17). Furthermore, polyclonal
anti-TNF-
antibody attenuated lung injury and the decrease in
oxygenation after lung lavage in animals ventilated with CMV (MVLP)
(17), suggesting the importance of TNF-
in this model.
In the present study, we found a significantly lower concentration of
TNF-
in the lung lavage fluid in the HFOV group, compared with the
MVLP or the LVHP group. In other models, injurious ventilatory
strategies have been shown to increase TNF-
in the circulation
draining an ex vivo perfused lung (50) or in the systemic
circulation in vivo in an acid aspiration rat model (7).
Ranieri et al. (34) demonstrated that a protective
ventilatory strategy produced a significant decrease in lavage and
serum TNF-
in humans. We do not mean to imply that TNF-
is the
only, or even the key, mediator released during VILI. Indeed, other
studies have suggested that TNF-
may not play a key role in VILI
(32, 48, 49). Pugin et al. (32) and Vlahakis
et al. (49) found no increase in TNF-
in stretched cell
culture systems. Verbrugge and colleagues (48) used an in
vivo rat lung lavage model and found that there were no statistically
significant increases in bronchoalveolar lavage TNF-
concentrations among animals treated with different ventilatory
strategies. Other chemokines or proinflammatory mediators such as
interleukin (IL)-8 or IL-1
and anti-inflammatory mediators such as
IL-10 have been measured in other studies, but these cytokines were not
measured in the present study. The balance of these pro- and
anti-inflammatory mediators is known to be important in the cytokine
network in the lung.
No significant differences in pathological changes in the alveoli were seen between the MVLP and LVHP groups. Our results are different from those of some other investigators (3, 9, 37). Corbridge and colleagues (9) studied different ventilatory strategies in a canine acid-aspiration model and concluded that ventilation with high VT and low PEEP augments lung edema and that PEEP protects against surfactant depletion. They used a VT of 30 ml/kg in the high-VT and low-PEEP group, which was markedly larger than our moderate VT (10-12 ml/kg). In contrast, membranous bronchiole pathological changes were greater in the MVLP group than in the LVHP group, consistent with the results of Muscedere and colleagues (28). During ventilation, a pressure wave is generated and travels down the airway, and at each point of the open airway the pressure is transmitted to the airway wall tangentially, producing large shear stresses, especially in regions where airways are collapsed; this may be responsible for the observed changes in the membranous bronchioles in the MVLP group. In the LVHP group, the degree of PEEP used may have been sufficient to keep the membranous bronchioles open at end-expiration. This could have protected these regions from repeated opening and closing, thus attenuating the trauma observed in the MVLP group. It is possible that membranous bronchioles were also held open during HFOV with a mean airway pressure of 15 cmH2O with only a small pressure oscillation around this and were not subjected to further trauma.
The increased injury in the MVLP group is unlikely to be due to the lower PaCO2 in this group because hypercapnic acidosis has been shown to attenuate lung injury in an isolated perfused rabbit model, possibly related to inhibition of endogenous xanthine oxidase (21, 22, 38). HFOV is thought to be an option of lung protection strategy without hypercapnia. In some clinical settings such as elevated intracranial pressure or inability to buffer CO2 adequately in the context of renal failure, these adverse effects of hypercapnia limit the use of "permissive hypercapnia."
It has been suggested that mechanical ventilation used in patients with
ARDS may serve to initiate and/or potentiate an inflammatory response
in the lung that in turn propagates a vicious cycle of inflammation
leading to tissue injury locally and possibly systemically (41,
46, 50). Results from our study suggest that the lower levels of
lung inflammation and TNF-
in the HFOV group compared with CMV may
be associated with a lower likelihood of propagation of this vicious
cycle of inflammation.
Early prospective, controlled clinical trials were unable to demonstrate the superiority of HFOV over CMV (16a). No benefit of HFOV accrued in the high-frequency intervention trial, and HFOV was associated with an increased incidence of air leak, intracranial hemorrhage, and periventricular leukomalacia. It has been suggested that this lack of benefit in the HIFI study was related to the lack of an adequate volume recruitment strategy (5). Recent studies using a volume recruitment strategy demonstrated improved gas exchange, reductions in barotrauma, and overall improved outcome in neonatal patients receiving HFOV (8, 15, 29). More recently, a pilot study demonstrated that HFOV using a protocol designed to obtain recruitment and maintain optimal lung volume was both safe and effective in pediatric and adult patients with ARDS (4, 12). The present study suggests that HFOV may be the preferable option as a lung protection strategy. Further prospective, controlled, clinical trials are needed to compare these two different means of pursuing the same physiological treatment goal, namely, that of recruiting and maintaining lung volume. Furthermore, a strategy with PEEP above Pinf may not be always possible during CMV because of hemodynamic compromise, despite VT reduction, and HFOV, by allowing such recruitment, may be a better lung protective strategy.
In summary, in this lung lavage model HFOV attenuated pulmonary
compliance, lung inflammation assessed by PMN infiltration, and TNF-
concentration in the alveolar space and pathological changes of the
small airways and alveoli. CMV using a protection ventilatory strategy
only attenuated the decrease in oxygenation and pulmonary compliance.
HFOV may therefore be a preferable option as a lung protection strategy.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Dr. A. Charles Bryan for useful comments in preparing this manuscript. We thank Drs. Marc de Perrot and George Volgyesi for kind assistance.
| |
FOOTNOTES |
|---|
This research was supported in part by The Ministry of Health and Welfare, Japan (H3-P-K-5), and the Canadian Institutes of Health Research.
Address for reprint requests and other correspondence: K. Miyasaka, National Children's Medical Research Center 3-35-31 Taishido, Setagaya-ku, Tokyo 154-8509, Japan (E-mail: kmiyasaka{at}nch.go.jp).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 18 January 2000; accepted in final form 15 June 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Acute Respiratory Distress Syndrome Network.
Ventilation with lower tidal volumes compared with traditional tidal volumes for acute lung injury, and the acute respiratory distress syndrome.
N Engl J Med
342:
1301-1308,
2000
2.
Amato, MB,
Barbas CS,
Medeiros DM,
Magaldi RB,
Schettino GP,
Lorenzi-Filho G,
Kairalla RA,
Deheinzelin D,
Munoz C,
Oliveira R,
Takagaki TY,
and
Carvalho CR.
Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome.
N Engl J Med
338:
347-354,
1998
3.
Argiras, EP,
Blakeley CR,
Dunnill MS,
Otremski S,
and
Sykes MK.
High PEEP decreases hyaline membrane formation in surfactant deficient lungs.
Br J Anaesth
59:
1278-1285,
1987
4.
Arnold, JH,
Hanson JH,
Toro-Figuero LO,
Gutierrez J,
Berens RJ,
and
Anglin DL.
Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure.
Crit Care Med
22:
1530-1539,
1994[ISI][Medline].
5.
Bryan, AC,
and
Froese AB.
Reflections on the HIFI trial.
Pediatrics
87:
565-567,
1991
7.
Chiumello, D,
Pristine G,
and
Slutsky AS.
Mechanical ventilation affects local and systemic cytokines in an animal model of acute respiratory distress syndrome.
Am J Respir Crit Care Med
160:
109-116,
1999
8.
Clark, RH,
Yoder BA,
and
Sell MS.
Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation.
J Pediatr
124:
447-454,
1994[ISI][Medline].
9.
Corbridge, TC,
Wood LD,
Crawford GP,
Chudoba MJ,
Yanos J,
and
Sznajder JI.
Adverse effects of large tidal volume and low PEEP in canine acid aspiration.
Am Rev Respir Dis
142:
311-315,
1990[ISI][Medline].
10.
DeLemos, RA,
Coalson JJ,
Gerstmann DR,
Null DM, Jr,
Ackerman NB,
Escobedo MB,
Robotham JL,
and
Kuehl TJ.
Ventilatory management of infant baboons with hyaline membrane disease: the use of high frequency ventilation.
Pediatr Res
21:
594-602,
1987[ISI][Medline].
11.
Dreyfuss, D,
and
Saumon G.
Ventilator-induced lung injury: lessons from experimental studies.
Am J Respir Crit Care Med
157:
294-323,
1998
12.
Fort, P,
Farmer C,
Westerman J,
Johannigman J,
Beninati W,
Dolan S,
and
Derdak S.
High-frequency oscillatory ventilation for adult respiratory distress syndrome
a pilot study.
Crit Care Med
25:
937-947,
1997[ISI][Medline].
13.
Froese, AB,
McCulloch PR,
Sugiura M,
Vaclavik S,
Possmayer F,
and
Moller F.
Optimizing alveolar expansion prolongs the effectiveness of exogenous surfactant therapy in the adult rabbit.
Am Rev Respir Dis
148:
569-577,
1993[ISI][Medline].
14.
Gattinoni, L,
Pesenti A,
Avalli L,
Rossi F,
and
Bombino M.
Pressure-volume curve of total respiratory system in acute respiratory failure. Computed tomographic scan study.
Am Rev Respir Dis
136:
730-736,
1987[ISI][Medline].
15.
Gerstmann, DR,
Minton SD,
Stoddard RA,
Meredith KS,
Monaco F,
Bertrand JM,
Battisti O,
Langhendries JP,
Francois A,
and
Clark RH.
The Provo multicenter early high-frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome.
Pediatrics
98:
1044-1057,
1996
16.
Hamilton, PP,
Onayemi A,
Smyth JA,
Gillan JE,
Cutz E,
Froese AB,
and
Bryan AC.
Comparison of conventional and high-frequency ventilation: oxygenation and lung pathology.
J Appl Physiol
55:
131-138,
1983
16a.
The HIFI Study Group.
High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants.
N Engl J Med
320:
88-93,
1989[Abstract].
17.
Imai, Y,
Kawano T,
Iwamoto S,
Nakagawa S,
Takata M,
and
Miyasaka K.
Intratracheal anti-tumor necrosis factor-
antibody attenuates ventilator-induced lung injury in rabbits.
J Appl Physiol
87:
510-515,
1999
18.
Imai, Y,
Kawano T,
Miyasaka K,
Takata M,
Imai T,
and
Okuyama K.
Inflammatory chemical mediators during conventional ventilation and during high frequency oscillatory ventilation.
Am J Respir Crit Care Med
150:
1550-1554,
1994[Abstract].
19.
Ito, Y,
Veldhuizen RA,
Yao LJ,
McCaig LA,
Bartlett AJ,
and
Lewis JF.
Ventilation strategies affect surfactant aggregate conversion in acute lung injury.
Am J Respir Crit Care Med
155:
493-499,
1997[Abstract].
20.
Kawano, T,
Mori S,
Cybulsky M,
Burger R,
Ballin A,
Cutz E,
and
Bryan AC.
Effect of granulocyte depletion in a ventilated surfactant-depleted lung.
J Appl Physiol
62:
27-33,
1987
21.
Laffey, JG,
Engelberts D,
and
Kavanagh BP.
Buffering hypercapnic acidosis worsens acute lung injury.
Am J Respir Crit Care Med
161:
141-146,
2000
22.
Laffey, JG,
and
Kavanagh BP.
Carbon dioxide and the critically ill
too little of a good thing?
Lancet
354:
1283-1286,
1999[ISI][Medline].
23.
Martynowicz, MA,
Minor TA,
Wilson TA,
Walters BJ,
and
Hubmayr RD.
Effect of positive end-expiratory pressure on regional lung expansion of oleic acid-injured dogs.
Chest
116:
28S-29S,
1999
24.
Matamis, D,
Lemaire F,
Harf A,
Brun-Buisson C,
Ansquer JC,
and
Atlan G.
Total respiratory pressure-volume curves in the adult respiratory distress syndrome.
Chest
86:
58-66,
1984
25.
Matsuoka, T,
Kawano T,
and
Miyasaka K.
Role of high-frequency ventilation in surfactant-depleted lung injury as measured by granulocytes.
J Appl Physiol
76:
539-544,
1994
26.
McCulloch, PR,
Forkert PG,
and
Froese AB.
Lung volume maintenance prevents lung injury during high frequency oscillatory ventilation in surfactant-deficient rabbits.
Am Rev Respir Dis
137:
1185-1192,
1988[ISI][Medline].
27.
Meredith, KS,
deLemos RA,
Coalson JJ,
King RJ,
Gerstmann DR,
Kumar R,
Kuehl TJ,
Winter DC,
Taylor A,
and
Clark RH.
Role of lung injury in the pathogenesis of hyaline membrane disease in premature baboons.
J Appl Physiol
66:
2150-2158,
1989
28.
Muscedere, JG,
Mullen JB,
Gan K,
and
Slutsky AS.
Tidal ventilation at low airway pressures can augment lung injury.
Am J Respir Crit Care Med
149:
1327-1334,
1994[Abstract].
29.
Ogawa, Y,
Miyasaka K,
Kawano T,
Imura S,
Inukai K,
Okuyama K,
Oguchi K,
Togari H,
Nishida H,
and
Mishina J.
A multicenter randomized trial of high frequency oscillatory ventilation as compared with conventional mechanical ventilation in preterm infants with respiratory failure.
Early Hum Dev
32:
1-10,
1993[ISI][Medline].
30.
Olson, LE,
and
Hoffman EA.
Heart-lung interactions determined by electron beam X-ray CT in laterally recumbent rabbits.
J Appl Physiol
78:
417-427,
1995
31.
Parker, JC,
Hernandez LA,
and
Peevy KJ.
Mechanisms of ventilator-induced lung injury.
Crit Care Med
21:
131-143,
1993[ISI][Medline].
32.
Pugin, J,
Dunn I,
Jolliet P,
Tassaux D,
Magnenat JL,
Nicod LP,
and
Chevrolet JC.
Activation of human macrophages by mechanical ventilation in vitro.
Am J Physiol Lung Cell Mol Physiol
275:
L1040-L1050,
1998
33.
Ranieri, VM,
Eissa NT,
Corbeil C,
Chasse M,
Braidy J,
Matar N,
and
Milic-Emili J.
Effects of positive end-expiratory pressure on alveolar recruitment and gas exchange in patients with the adult respiratory distress syndrome.
Am Rev Respir Dis
144:
544-551,
1991[ISI][Medline].
34.
Ranieri, VM,
Suter PM,
Tortorella C,
De Tullio R,
Dayer JM,
Brienza A,
Bruno F,
and
Slutsky AS.
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial.
JAMA
282:
54-61,
1999
35.
Rimensberger, PC,
Cox PN,
Frndova H,
and
Bryan AC.
The open lung during small tidal volume ventilation: concepts of recruitment and "optimal" positive end-expiratory pressure.
Crit Care Med
27:
1946-1952,
1999[ISI][Medline].
36.
Ruckebusch, Y,
Phaneuf L,
and
Dunlop R.
Physiology of Small and Large Animals. Philadelphia, PA: B. C. Decker, 1991, p. 43-97.
37.
Sandhar, BK,
Niblett DJ,
Argiras EP,
Dunnill MS,
and
Sykes MK.
Effects of positive end-expiratory pressure on hyaline membrane formation in a rabbit model of the neonatal respiratory distress syndrome.
Intensive Care Med
14:
538-546,
1988[ISI][Medline].
38.
Shibata, K,
Cregg N,
Engelberts D,
Takeuchi A,
Fedorko L,
and
Kavanagh BP.
Hypercapnic acidosis may attenuate acute lung injury by inhibition of endogenous xanthine oxidase.
Am J Respir Crit Care Med
158:
1578-1584,
1998
39.
Slutsky, AS.
Consensus conference on mechanical ventilation
January 28-30, 1993 at Northbrook, Illinois, USA. Part 2.
Intensive Care Med
20:
150-162,
1994[ISI][Medline].
40.
Slutsky, AS.
Lung injury caused by mechanical ventilation.
Chest
116:
9S-15S,
1999
41.
Slutsky, AS,
and
Tremblay LN.
Multiple system organ failure. Is mechanical ventilation a contributing factor?
Am J Respir Crit Care Med
157:
1721-1725,
1998
42.
Sugiura, M,
McCulloch PR,
Wren S,
Dawson RH,
and
Froese AB.
Ventilator pattern influences neutrophil influx and activation in atelectasis-prone rabbit lung.
J Appl Physiol
77:
1355-1365,
1994
43.
Takata, M,
Abe J,
Tanaka H,
Kitano Y,
Doi S,
Kohsaka T,
and
Miyasaka K.
Intraalveolar expression of tumor necrosis factor-
gene during conventional and high-frequency ventilation.
Am J Respir Crit Care Med
156:
272-279,
1997
44.
Tremblay, L,
Valenza F,
Ribeiro SP,
Li J,
and
Slutsky AS.
Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model.
J Clin Invest
99:
944-952,
1997[ISI][Medline].
45.
Truog, WE,
and
Standaert TA.
Effect of high-frequency ventilation on gas exchange and pulmonary vascular resistance in lambs.
J Appl Physiol
59:
1104-1109,
1985
46.
Tutor, JD,
Mason CM,
Dobard E,
Beckerman RC,
Summer WR,
and
Nelson S.
Loss of compartmentalization of alveolar tumor necrosis factor after lung injury.
Am J Respir Crit Care Med
149:
1107-1111,
1994[Abstract].
47.
Venegas, JG,
and
Fredberg JJ.
Understanding the pressure cost of ventilation: why does high-frequency ventilation work?
Crit Care Med
22:
S49-S57,
1994[ISI][Medline].
48.
Verbrugge, SJ,
Uhlig S,
Neggers SJ,
Martin C,
Held HD,
Haitsma JJ,
and
Lachmann B.
Different ventilation strategies affect lung function but do not increase tumor necrosis factor-
and prostacyclin production in lavaged rat lungs in vivo.
Anesthesiology
91:
1834-1843,
1999[ISI][Medline].
49.
Vlahakis, NE,
Schroeder MA,
Limper AH,
and
Hubmayr RD.
Stretch induces cytokine release by alveolar epithelial cells in vitro.
Am J Physiol Lung Cell Mol Physiol
277:
L167-L173,
1999
50.
Von Bethmann, AN,
Brasch F,
Nusing R,
Vogt K,
Volk HD,
Muller KM,
Wendel A,
and
Uhlig S.
Hyperventilation induces release of cytokines from perfused mouse lung.
Am J Respir Crit Care Med
157:
263-272,
1998
51.
Wright, JL,
Cosio M,
Wiggs B,
and
Hogg JC.
A morphologic grading scheme for membranous and respiratory bronchioles.
Arch Pathol Lab Med
109:
163-165,
1985[ISI][Medline].
This article has been cited by other articles:
![]() |
Rebuttal from Drs. Ferguson and Slutsky J Appl Physiol, April 1, 2008; 104(4): 1233 - 1234. [Full Text] [PDF] |
||||
![]() |
N. D. Ferguson and A. S. Slutsky Point:Counterpoint: High-frequency ventilation is/is not the optimal physiological approach to ventilate ARDS patients J Appl Physiol, April 1, 2008; 104(4): 1230 - 1231. [Full Text] [PDF] |
||||
![]() |
K. P. W. Chan, T. E. Stewart, and S. Mehta High-Frequency Oscillatory Ventilation for Adult Patients With ARDS Chest, June 1, 2007; 131(6): 1907 - 1916. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Frank, P. E. Parsons, and M. A. Matthay Pathogenetic Significance of Biological Markers of Ventilator-Associated Lung Injury in Experimental and Clinical Studies Chest, December 1, 2006; 130(6): 1906 - 1914. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mehta, J. Granton, R. J. MacDonald, D. Bowman, A. Matte-Martyn, T. Bachman, T. Smith, and T. E. Stewart High-Frequency Oscillatory Ventilation in Adults: The Toronto Experience Chest, August 1, 2004; 126(2): 518 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Wilson, S. Choudhury, M. E. Goddard, K. P. O'Dea, A. G. Nicholson, and M. Takata High tidal volume upregulates intrapulmonary cytokines in an in vivo mouse model of ventilator-induced lung injury J Appl Physiol, October 1, 2003; 95(4): 1385 - 1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Imai, J. Parodo, O. Kajikawa, M. de Perrot, S. Fischer, V. Edwards, E. Cutz, M. Liu, S. Keshavjee, T. R. Martin, et al. Injurious Mechanical Ventilation and End-Organ Epithelial Cell Apoptosis and Organ Dysfunction in an Experimental Model of Acute Respiratory Distress Syndrome JAMA, April 23, 2003; 289(16): 2104 - 2112. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Derdak, S. Mehta, T. E. Stewart, T. Smith, M. Rogers, T. G. Buchman, B. Carlin, S. Lowson, J. Granton, and the Multicenter Oscillatory Ventilation High-Frequency Oscillatory Ventilation for Acute Respiratory Distress Syndrome in Adults: A Randomized, Controlled Trial Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 801 - 808. [Abstract] [Full Text] |
||||
| ||||||||||||